Xfinito Biodesigns
About Xfinito Biodesigns
Neurological disorders are now the leading source of disability globally, and ageing increases the burden of neurodegenerative disorders like Cerebral Atrophy, Parkinson's disease, Dementia etc. According to a study, Globally, there are around 50 million patients, and India has approximately 7 million elders who have Parkinson's. The number of patients with Dementia and Atrophy is increasing exponentially. Also, based on a recent study, many patients who recovered from Covid-19 showed neurological symptoms. Finally, with the current lifestyle, stress is one of the issues of neurological disorders. Our solution will bring help in better management of the condition and, at the same time, support clinicians to provide and monitor the treatment, which could potentially reduce the disability caused due to neurodegeneration.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 2150000 INR
- Last Funding: 1150000 INR (Grant)
- Funding Status:
Technology Stack
Xfinito Biodesigns actively uses None products in their tech stack.
Market Presence
Industries: Health Care, Medical, Software
Headquarters: Bangalore City, Karnataka, India